Cost Analysis of Bariatric Surgery in an Employee-based Healthcare System Following Surgery Coverage
NCT ID: NCT02381704
Last Updated: 2015-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2008-04-30
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
NCT01162668
Outcome of Bariatric Surgery in Patients With BMI Greater Than 60 .
NCT04663425
Quality of Life Outcomes and Economic Impacts of Bariatric Surgery
NCT00850356
Effect of Bariatric Surgery on Brain Insulin Sensitivity
NCT03705923
Obstructive Sleep Apnea in Bariatric Surgical Patients
NCT01852305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Despite the well-documented benefits of bariatric surgery in terms of health and healthcare costs, many insurers deny coverage for the surgery out of fear that the cost of surgery will financially burden the system. These insurers, however, fail to consider the improvement in obesity-related diseases and associated cost savings. The recent change in policy by the Florida Hospital Healthcare System (FHHS) that allows for partial coverage of bariatric surgery provides the unique opportunity to study prospectively the cost effectiveness of the surgery, i.e. cost of surgery vs. cost savings. Study participants will include approximately 75 to 100 FHHS covered individuals (18 to 64 years) who have been approved for bariatric surgery and who have provided their written consent for study participation.
The study protocol will include a review of patient insurance records for cost analysis of medication and medical expenses prior to surgery and over a two-year period postoperatively. Patients will also be asked to consent to the completion of a yearly questionnaire concerning the status of their obesity co-morbidities, medication use and dosage, and sick leave. The outcome of this prospective study will allow for assessment of the costs of surgery, cost saving in terms of medication and medical expenses, and the potential time period required for return on investment. Such data, when shared with others through peer-review journal publications, may assist other employee healthcare systems in their decision to provide coverage for bariatric procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been approved for bariatric surgery
* Have provided their written consent for study participation.
Exclusion Criteria
* Surgery exclusion:
BMI less than or equal to 35 without at least two major co-morbidities pregnancy active alcoholism or drug abuse suicidal ideation cancer or another wasting disease mental handicap and inability to provide written consent.
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ethicon Endo-Surgery
INDUSTRY
AdventHealth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Keith Kim
Director of Metabolic Medicine & Surgery Institute at Celebration Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith C Kim, MD
Role: PRINCIPAL_INVESTIGATOR
Advanced Minimally Invasive and Bariatric Surgery Consultants
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Advanced Minmially Invasive and Bariatric Surgery Consultants
Celebration, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Seidell JC. Obesity, insulin resistance and diabetes--a worldwide epidemic. Br J Nutr. 2000 Mar;83 Suppl 1:S5-8. doi: 10.1017/s000711450000088x.
Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002 Oct 9;288(14):1723-7. doi: 10.1001/jama.288.14.1723.
Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002 Oct 9;288(14):1728-32. doi: 10.1001/jama.288.14.1728.
Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA. 2002 Oct 9;288(14):1758-61. doi: 10.1001/jama.288.14.1758.
Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999 Oct 27;282(16):1519-22. doi: 10.1001/jama.282.16.1519.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999 Oct 7;341(15):1097-105. doi: 10.1056/NEJM199910073411501.
Drenick EJ, Bale GS, Seltzer F, Johnson DG. Excessive mortality and causes of death in morbidly obese men. JAMA. 1980 Feb 1;243(5):443-5.
McGee DL; Diverse Populations Collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005 Feb;15(2):87-97. doi: 10.1016/j.annepidem.2004.05.012.
Sjostrom LV. Mortality of severely obese subjects. Am J Clin Nutr. 1992 Feb;55(2 Suppl):516S-523S. doi: 10.1093/ajcn/55.2.516s.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. doi: 10.1001/jama.292.14.1724.
Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005 Apr 5;142(7):547-59. doi: 10.7326/0003-4819-142-7-200504050-00013.
Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004 Sep;240(3):416-23; discussion 423-4. doi: 10.1097/01.sla.0000137343.63376.19.
Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006 Oct;81(10 Suppl):S46-51. doi: 10.1016/s0025-6196(11)61180-4.
O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006 Aug;16(8):1032-40. doi: 10.1381/096089206778026316.
Sugerman HJ. Bariatric surgery for severe obesity. J Assoc Acad Minor Phys. 2001 Jul;12(3):129-36.
Martin LF, Lundberg AP, Juneau F, Raum WJ, Hartman SJ. A description of morbidly obese state employees requesting a bariatric operation. Surgery. 2005 Oct;138(4):690-700; discussion 700. doi: 10.1016/j.surg.2005.06.050.
Finkelstein EA, Brown DS. A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care. 2005 Oct;11(10):641-6.
Scheen AJ, Letiexhe M, Rorive M, De Flines J, Luyckx FH, Desaive C. [Bariatric surgery: 10-year results of the Swedish Obese Subjects Study]. Rev Med Liege. 2005 Feb;60(2):121-5. French.
Long SD, O'Brien K, MacDonald KG Jr, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care. 1994 May;17(5):372-5. doi: 10.2337/diacare.17.5.372.
MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997 May-Jun;1(3):213-20; discussion 220. doi: 10.1016/s1091-255x(97)80112-6.
Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother. 2005 Apr;39(4):637-42. doi: 10.1345/aph.1E393. Epub 2005 Mar 1.
Monk JS Jr, Dia Nagib N, Stehr W. Pharmaceutical savings after gastric bypass surgery. Obes Surg. 2004 Jan;14(1):13-5. doi: 10.1381/096089204772787220.
Potteiger CE, Paragi PR, Inverso NA, Still C, Reed MJ, Strodel W 3rd, Rogers M, Petrick A. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg. 2004 Jun-Jul;14(6):725-30. doi: 10.1381/0960892041590999.
Gould JC, Garren MJ, Starling JR. Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months. J Gastrointest Surg. 2004 Dec;8(8):983-7. doi: 10.1016/j.gassur.2004.09.042.
Nguyen NT, Varela JE, Sabio A, Naim J, Stamos M, Wilson SE. Reduction in prescription medication costs after laparoscopic gastric bypass. Am Surg. 2006 Oct;72(10):853-6.
Snow LL, Weinstein LS, Hannon JK, Lane DR, Ringold FG, Hansen PA, Pointer MD. The effect of Roux-en-Y gastric bypass on prescription drug costs. Obes Surg. 2004 Sep;14(8):1031-5. doi: 10.1381/0960892041975677.
Fang J. The cost-effectiveness of bariatric surgery. Am J Gastroenterol. 2003 Sep;98(9):2097-8. doi: 10.1111/j.1572-0241.2003.07671.x.
Martin LF, Tan TL, Horn JR, Bixler EO, Kauffman GL, Becker DA, Hunter SM. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995 Oct;118(4):599-606; discussion 606-7. doi: 10.1016/s0039-6060(05)80024-8.
Sampalis JS, Liberman M, Auger S, Christou NV. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg. 2004 Aug;14(7):939-47. doi: 10.1381/0960892041719662.
Gallagher SF, Banasiak M, Gonzalvo JP, Paoli DP, Allwood J, Morris D, Murr MM, Shapiro DH. The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis. Obes Surg. 2003 Apr;13(2):245-8. doi: 10.1381/096089203764467144.
Gorman RS, Stern DL, Inclan DV, Presutti RJ, Swain JM, Hentz JG. Outcomes, health status, and medical resource utilization after bariatric surgery. Compr Ther. 2006 Spring;32(1):34-8. doi: 10.1385/comp:32:1:34.
Kuhlmann HW, Falcone RA, Wolf AM. Cost-effective bariatric surgery in Germany today. Obes Surg. 2000 Dec;10(6):549-52. doi: 10.1381/096089200321594156.
Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006 Nov;16(11):1488-503. doi: 10.1381/096089206778870067.
Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord. 2003 Oct;27(10):1167-77. doi: 10.1038/sj.ijo.0802394.
Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. doi: 10.3310/hta8210.
Finkelstein EA, Brown DS, Avidor Y, Takeuchi AH. The role of price, sociodemographic factors, and health in the demand for bariatric surgery. Am J Manag Care. 2005 Oct;11(10):630-7.
Sadhasivam S, Larson CJ, Lambert PJ, Mathiason MA, Kothari SN. Refusals, denials, and patient choice: reasons prospective patients do not undergo bariatric surgery. Surg Obes Relat Dis. 2007 Sep-Oct;3(5):531-5; discussion 535-6. doi: 10.1016/j.soard.2007.07.004.
Nguyen NT, Paya M, Stevens CM, Mavandadi S, Zainabadi K, Wilson SE. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg. 2004 Oct;240(4):586-93; discussion 593-4. doi: 10.1097/01.sla.0000140752.74893.24.
Murr MM, Martin T, Haines K, Torrella T, Dragotti R, Kandil A, Gallagher SF, Harmsen S. A state-wide review of contemporary outcomes of gastric bypass in Florida: does provider volume impact outcomes? Ann Surg. 2007 May;245(5):699-706. doi: 10.1097/01.sla.0000256392.04141.04.
6. CDC. Obesity and overweight trends. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/index.htm
Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006 Nov;73(11):993-1007. doi: 10.3949/ccjm.73.11.993.
Buffington CK, Cowan GSM, Jr. Gastric Bypass in the Treatment of Diabetes, Hypertension and Lipid/lipoprotein Abnormalities of the Morbidly Obese. In Deitel M (ed.): Companion Volume to Obesity Surgery for the Morbidly Obese Patient. 2000 by FD Publications, Toronto, Canada, pp. 435-450.
North American Association for the Study of Obesity and the National Heart, Lung, and Blood Institute. The practical guide: identification, evaluation and treatment of overweight and obesity in adults. Bethesda, MD. National Institutes of Health, 2000, NIH Publication 00-4084.
North American Association for the Study of Obesity and the National Heart, Lung, and Blood Institute. Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. Bethesda, Md: National Institutes of Health, 1998. NIH Publication 98-4083.
Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003641. doi: 10.1002/14651858.CD003641.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08.03.08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.